| Items | Drug Registration information |
|---|---|
| ID | 1629 |
| No | 1629 |
| Brand Name | APIXA |
| Ingredients | APIXABAN 2.5 MG |
| Dosage Form | TABLET |
| Primary Packaging | BOTTLE |
| Storage | |
| Shelf Life | 2 YEARS |
| Pack Size | 28 TABLETS/BOTTLE |
| Dispensing Category | |
| ATC Classification | |
| Pharmaceutical Class | |
| Indications | REDUCING THE RISK OF STROKE AND SYSTEMIC EMBOLISM IN PATIENTS WHO HAVE NONVALVULAR ATRIAL FIBRILLATION, PROPHYLAXIS OF DEEP VEIN THROMBOSIS(DVT) LEADING TO PULMONARY EMBOLISM(PE) IN PATIENTS AFTER A HIP OR KNEE REPLACEMENT SURGERY |
| Contraindications | |
| Side Effects | |
| Unit Price | |
| EDL | NULL |
| Description | YELLOW ROUND TABLET |
| Note | |
| License Owner | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
| Manufacturer | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
| Country | LAOS |
| Import Registration No | |
| Import Registration Date | |
| Activity | CERTIFICATE RELEASED |
| Applied Date | |
| FDD Registration No | 09 L 1018/23 |
| FDD Registration Date | 20/09/2023 |
| Expiry Date | 19/09/2026 |